Goldman Sachs Group Inc Uni Qure N.V. Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 259,637 shares of QURE stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

259,637

Previous 317,637 18.26%

Holding current value

$3.69 Million

Previous $3.37 Million 18.24%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 16, 2025	SELL	$10.6 - $18.08 $614,800 - $1.05 Million	-58,000 Reduced 18.26%	259,637 $2.75 Million
Q1 2025 May 09, 2025	BUY	$10.6 - $18.08 $2.53 Million - $4.31 Million	238,313 Added 300.43%	317,637 $3.37 Million
Q4 2024 Feb 11, 2025	SELL	$4.54 - $17.73 $1.11 Million - $4.32 Million	-243,840 Reduced 75.45%	79,324 $1.4 Million
Q3 2024 Nov 14, 2024	BUY	$3.78 - $10.12 $74,518 - $199,505	19,714 Added 6.5%	323,164 $1.59 Million
Q2 2024 Aug 13, 2024	SELL	$4.39 - $5.43 $258,496 - $319,734	-58,883 Reduced 16.25%	303,450 $1.36 Million
Q1 2024 May 15, 2024	SELL	$4.82 - $6.93 $1.61 Million - $2.31 Million	-333,012 Reduced 47.89%	362,333 $1.88 Million
Q4 2023 Feb 13, 2024	BUY	$5.63 - $8.27 $1.31 Million - $1.93 Million	233,526 Added 50.57%	695,345 $4.71 Million
Q3 2023 May 14, 2024	SELL	$6.71 - $11.83 $1.57 Million - $2.76 Million	-233,526 Reduced 33.58%	461,819 $3.1 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $190,530 - $335,912	28,395 Added 6.55%	461,819 $3.1 Million
Q2 2023 May 14, 2024	BUY	$11.12 - $22.2 $46,014 - $91,863	4,138 Added 0.96%	433,424 $4.97 Million
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $46,014 - $91,863	4,138 Added 0.96%	433,424 $4.97 Million
Q1 2023 May 14, 2024	SELL	$18.7 - $23.07 $128,469 - $158,490	-6,870 Reduced 1.58%	429,286 $8.65 Million
Q1 2023 May 11, 2023	SELL	$18.7 - $23.07 $128,469 - $158,490	-6,870 Reduced 1.58%	429,286 $8.65 Million
Q4 2022 May 14, 2024	SELL	$18.12 - $27.32 $621,987 - $937,786	-34,326 Reduced 7.3%	436,156 $9.89 Million
Q4 2022 Feb 13, 2023	SELL	$18.12 - $27.32 $621,987 - $937,786	-34,326 Reduced 7.3%	436,156 $9.89 Million
Q3 2022 May 14, 2024	BUY	$16.98 - $25.54 $1.15 Million - $1.73 Million	67,551 Added 16.76%	470,482 $8.83 Million
Q3 2022 Nov 10, 2022	BUY	$16.98 - $25.54 $1.15 Million - $1.73 Million	67,551 Added 16.76%	470,482 $8.83 Million
Q2 2022 May 14, 2024	SELL	$13.15 - $20.45 $3.85 Million - $5.98 Million	-292,414 Reduced 42.05%	402,931 $7.51 Million
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $1.32 Million - $2.05 Million	100,241 Added 33.12%	402,931 $7.51 Million
Q1 2022 May 16, 2022	SELL	$14.54 - $21.5 $203,080 - $300,290	-13,967 Reduced 4.41%	302,690 $5.47 Million
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $5.16 Million - $9.19 Million	-255,112 Reduced 44.62%	316,657 $6.57 Million
Q3 2021 Nov 10, 2021	BUY	$26.01 - $38.22 $14.9 Million - $21.9 Million	571,769 New	571,769 $18.3 Million

Others Institutions Holding QURE

# of Institutions

178

Shares Held

50.7M

Call Options Held

2.13M

Put Options Held

480K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $664M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Uni Qure N.V. Transaction History